Combatting maternal and neonatal sepsis will save lives and directly contribute to the achievement of SDG 3, which promotes good health and well-being. But the true burden of maternal and neonatal sepsis is presently unknown, owing to a lack of data.
GLOSS, the Global Maternal Sepsis Study, will help to quantify the true burden and assess the current management of maternal and neonatal sepsis. The Study will look at how women with infection during pregnancy, childbirth or postpartum, or post-abortion are identified and treated in participating hospitals.
Over the course of one week, the study will prompt a massive coordinated data collection effort in approximately 500 healthcare facilities in 54 countries across the world. The new and potential identification criteria will be tested and validated in this large global study.
To learn more about the study, please contact us.